123 116

Cited 69 times in

Expression of Bcl-2 family member Bid in normal and malignant tissues

Authors
 Maryla Krajewska  ;  Juan M Zapata  ;  Ivo Meinhold Heerlein  ;  Hirad Hedayat  ;  Anne Monks  ;  Herta Bettendorf  ;  Ahmed Shabaik  ;  Lukas Bubendorf  ;  Olli P Kallioniemi  ;  Hoguen Kim  ;  Guido Reifenberger  ;  John C Reed  ;  Stanislaw Krajewski 
Citation
 NEOPLASIA, Vol.4(2) : 129-140, 2002 
Journal Title
 NEOPLASIA 
ISSN
 1522-8002 
Issue Date
2002
Keywords
Bid ; Bcl - 2 ; apoptosis ; cancer ; tissue microarrays
Abstract
Bid is the only known Bcl-2 family member that can function as an agonist of proapoptotic Bcl-2-related proteins such as Bax and Bak. Expression of the proapoptotic Bcl-2 family protein Bid was assessed by immunoblotting and immunohistochemical methods in normal murine and human-tissues and in several types of human cancers and tumor cell lines. Bid expression in normal tissues varied widely, with prominent Bid immunostaining occurring in several types of short-lived cells (e.g., germinal center B cells, peripheral blood granulocytes, differentiated keratinocytes) and in apoptosissensitive cells (e.g., adult neurons). Analysis of Bid expression by immunostaining of 100 colon, 95 ovarian, and 254 prostate cancers, as well as 59 brain tumors and 50 lymphomas, revealed evidence of altered Bid regulation in sometypes of cancers. Correlations with clinical outcome data revealed association of higher levels of Bid with longer recurrence-free survival in men with locally advanced (T3 stage) prostate cancer (P=0.04). Immunoblot analysis of Bid protein levels in the NCI's panel of 60 human tumor cell lines revealed a correlation between higher levels of Bid and sensitivity to ribonucleotide reductase (RR)-inhibiting drugs (P<0.0005). Overexpression of Bid in a model tumor cell line by gene transfection resulted in increased sensitivity to apoptosis induction by a RR inhibitor. Taken together, these observations suggest a potential role for Bid in tumor responses to specific chemotherapeutic drugs, and lay a foundation for future investigations of this member of the Bcl-2 family in healthy and diseased tissues.
Files in This Item:
T200205919.pdf Download
DOI
10.1038/sj/neo/7900222
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
Yonsei Authors
Kim, Hogeun(김호근)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/143926
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links